Upstream Works, Aceyus to pioneer customer experience solutions
Category: #tech  By Mateen Dalal  Date: 2019-09-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

Upstream Works, Aceyus to pioneer customer experience solutions

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to enhance their product offerings and customer satisfaction.   

Upstream Works Software Ltd., the Ontario based software company that offers Omnichannel Contact Center solutions, is one such firm that has recently inked a partnership agreement with Aceyus, a forerunner in contact center innovations that helps enhance and manage employee and customer experience.

According to reports, the venture would focus on enriching customer experience management with informative data that enables improved performance and informed decisions.

Currently, Upstream Works offers Cisco Finesse desktop with its omnichannel CX management solutions, along with intuitive workspace for supervisors and agents to deliver well informed, personalized customer experiences while gathering crucial conversational data.

The company’s UWF (Upstream Works for Finesse) was awarded 2019 CUSTOMER Product of the Year by TMC, a renowned media company, making it the firm’s third consecutive year to bag this recognition for its outstanding customer experience omnichannel solutions on Cisco communications platform.

Speaking on its partnership, Rob McDougall, President and CEO, Upstream Works, said that the company is excited about this collaboration with Aceyus. This venture would benefit both the organizations by providing an extensive amount of data, and offering them an aggressive advantage while building its digital transformation goals.

As for Mike Ary, President and CEO, Aceyus, this venture would help sellers recognize its customers journey, informing them with insightful information that could optimize contact center performance and advance experience. 

In addition to its partnership with Aceyus, Upstream Works has also recently entered into a deal with Local Measure, an Australian based CX platform that offers best customer experience services for operations with real-world, physical presence.

As per sources, the partnership focuses on offering brands with a comprehensive and seamless solution to provide real-time social and customer engagement excellence across businesses.

Source Credit: https://www.upstreamworks.com/upstream-works-software-partners-with-aceyus-on-customer-experience-management-solutions/

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Cryptocurrency platform Binance acquires dApp startup DappReview
Cryptocurrency platform Binance acquires dApp startup DappReview
By Mateen Dalal

Binance, a renowned cryptocurrency exchange platform where more than 100 cryptocurrencies are traded, reportedly announced the acquisition of DappReview, an evaluation platform offering advertising and data-driven research services to blockchain-base...

Amneal gains FDA nod for launch of Revatio® & Amicar® tablets
Amneal gains FDA nod for launch of Revatio® & Amicar® tablets
By Mateen Dalal

Amneal Pharmaceuticals, Inc. has made some consistent ripples in the generics and specialty pharmaceutical industry. Recently, the company made headlines when it revealed attaining final approval from the U.S. FDA on its ANDA (Abbreviated New Drug Ap...

Prescient expands PTX-200 trial after it eradicates cancer completely
Prescient expands PTX-200 trial after it eradicates cancer completely
By Mateen Dalal

Prescient Therapeutics, a renowned small molecule drug development firm aimed at developing new cancer therapies, reportedly announced that it is extending its Phase 1b trial in patients with AML (acute myeloid leukemia) after the disease was complet...